Identity
- Security key
- 20815
- Ticker
- RCKT
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2015-02-18
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- RCKT
Detail
Enriched 2026-08-14 20:47
- Market cap
- $374,331,375.77
- Shares outstanding (class)
- 109,193,549
- Shares outstanding (weighted)
- 109,774,597
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 202
- Location
- NEW YORK, NY
- Homepage
- https://www.rocketpharma.com
- Description
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Market cap and share counts drift.